Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids

Digestive and Liver Disease

Volumn 44, Issue 3, 2012, Pages 206-210

  Garcia Planella, Esther ^a   Mañosa, Míriam ^b,d   van Domselaar, Manuel ^c   Gordillo, Jordi ^a   Zabana, Yamile ^b,d   Cabré, Eduard ^b,d   López San Román, Antonio ^c   Domènech, Eugeni ^b,d  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Colectomy; Corticosteroids; Infliximab; Thiopurines; Ulcerative colitis

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; MESALAZINE;

ADULT; ARTICLE; CLINICAL ASSESSMENT; COLON RESECTION; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HIGH RISK PATIENT; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRESCRIPTION; PRIORITY JOURNAL; RELAPSE; REMISSION; RISK FACTOR; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; CHI-SQUARE DISTRIBUTION; COLECTOMY; COLITIS, ULCERATIVE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; MALE; MESALAMINE; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84856586863     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.10.004     Document Type: Article

References (19)

1. Peyrin-Biroulet L., Loftus E.V., Colombel J.F., et al. Early Crohn disease: a proposed definition for use in disease-modification trials. Gut 2010, 59:141-147.
2. Beaugerie L., Seksik P., Nion-Larmurier I., et al. Predictors of Crohn's disease. Gastroenterology 2006, 130:650-656.
3. Loly C., Belaiche J., Louis E. Predictors of severe Crohn's disease. Scand J Gastroenterol 2008, 43:948-954.
4. Domènech E., Mañosa M., Cabré E. Top-down therapy: is the evidence strong enough?. Dig Dis 2009, 27:306-311.
5. Travis S.P.L., Stange E.F., Lémann M., et al. European evidence-based Consensus on the management of ulcerative colitis: current management. J Crohn Colitis 2002, 2:24-62.
6. Faubion W.A., Loftus E.V., Harmsen W.S., et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population based study. Gastroenterology 2001, 121:255-260.
7. Ho G.T., Chiam P., Drummond H., et al. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther 2006, 24:319-330.
8. García-López S., Gomollón F., Gisbert J.P. Cyclosporine in the treatment of severe attack of ulcerative colitis: a systematic review. Gastroenterol Hepatol 2005, 28:607-614.
9. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989, 24(Suppl. 170):2-6.
10. Silverberg M.S., Satsangi J., Ahmad T., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(Suppl. A):5-36.
11. Travis S.P., Farrant J.M., Ricketts C., et al. Predicting outcome in severe ulcerative colitis. Gut 1996, 38:905-910.
12. Daperno M., Sostegni R., Scaglione N., et al. Outcome of a conservative approach in severe ulcerative colitis. Dig Liver Dis 2004, 36:21-28.
13. Mañosa M., Cabré E., Garcia-Planella E., et al. Decision tree for early introduction of rescue therapy in active UC treated with steroids. Inflamm Bowel Dis 2011, [Epub ahead of print]. 10.1002/ibd.21634.
14. Allison J., Herrinton L.J., Liu L., et al. Natural history of severe ulcerative colitis in a community-based health plan. Clin Gastroenterol Hepatol 2008, 6:999-1003.
15. Gustavsson A., Halfvarson J., Magnuson A., et al. Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era. Am J Gastroenterol 2007, 102:2513-2519.
16. Elliott P.R., Powell-Tuck J., Gillespie P.E., et al. Prednisolone absorption in acute colitis. Gut 1980, 21:49-51.
17. Lau A., Chande N., Ponich T., et al. Predictive factors associated with immunosuppressive agent use in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 2008, 28:606-613.
18. Froslie K.F., Jahnsen J., Moum B.A., et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007, 133:412-422.
19. Kane S.V. Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther 2006, 23:577-585.